National trend in prevalence, cost, and discharge disposition after subdural hematoma from 1998-2007
ABSTRACT Subdural hematoma is a common type of intracranial hemorrhage, particularly among the elderly, yet, despite the aging U.S. population, little has been published in the last 10 yrs. This study aimed to determine national trends in prevalence, discharge disposition, length of stay, and cost of subdural hematoma over time.
Retrospective cohort study.
Adult patients hospitalized in the United States between 1998 and 2007 identified in the Nationwide Inpatient Sample.
Seven hundred twenty thousand, two hundred ninety-seven adult patients hospitalized in subdural hematoma.
Discharge disposition, hospital length of stay, and national cost (adjusted to 2007 dollars) were examined. Hospitalizations for subdural hematoma increased from 59,373 (30 per 100,000 hospitalizations) in 1998 to 91,935 (42 per 100,000) in 2007, constituting a 39% per-capita increase. The prevalence of subdural hematoma increased with age (p < .001), particularly among those >80 yrs of age (36% of subdural hematoma cohort), in lower income patients, in patients with acquired abnormalities of the coagulation cascade, and in patients with trauma. Inhospital mortality decreased from 15% to 12% (p = .001), but unsatisfactory discharge disposition increased from 17% to 20% (p < .001). National cost increased from $1.0 to $1.6 billion (p < .001). Unsatisfactory discharge disposition and cost were both independently predicted by higher comorbidity index, alcohol abuse, history of trauma, and acquired abnormal coagulation or platelet factors (p < .05). Neurosurgical intervention for subdural hematoma decreased from 41% in 1998 to 31% in 2007 (p < .001). Subdural hematoma evacuation was associated with decreased mortality but did not significantly protect against poor discharge disposition and was associated with significantly higher cost.
The prevalence and total cost for subdural hematoma has increased significantly in the last decade nationwide. Health resource consumption for subdural hematoma is increasing without clear evidence that management practices are leading to improved outcomes.
SourceAvailable from: Miikka Korja[Show abstract] [Hide abstract]
ABSTRACT: Preoperative risk scores are designed to guide patient management by providing a means of predicting operative outcome. Several risk scores are used in neurosurgery, but studies on their clinical relevance are scarce. Therefore, it is not clear whether these risk scores are beneficial or helpful in predicting outcome after elective cranial neurosurgery. In this review, we summarize the current scientific evidence for using preoperative risk scores in elective cranial neurosurgery.Anesthesia and analgesia 08/2014; 119(2):420-432. DOI:10.1213/ANE.0000000000000234 · 3.42 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: Subdural hematoma (SDH) is a well described risk factor in the development of Status Epilepticus (SE), however the epidemiology of SE after SDH is unknown. In this study, we sought to determine the epidemiology of SE, the prevalence of risk factors, and impact on hospital mortality using a large administrative dataset.SpringerPlus 01/2014; 3:332. DOI:10.1186/2193-1801-3-332
[Show abstract] [Hide abstract]
ABSTRACT: Abstract Stroke is a leading cause of mortality and acquired disability, however, there has been no comprehensive comparison of co-morbid risk factors between different stroke subtypes. The aim of this study was to compare risk factors and mortality for subdural haematoma (SDH), subarachnoid haemorrhage (SAH), ischaemic and haemorrhagic stroke. We compiled a database of all patients admitted with these conditions admitted to a large teaching hospital in Birmingham, UK during the period 2000-2007 using the International Classification of Disease (ICD) 10(th) revision codes. Generalised linear models were constructed to calculate relative risks (RRs) associated with co-morbidities. 4804 patients were admitted with diagnoses of SDH (1004), SAH (807), ischaemic stroke (2579) and haemorrhagic stroke (414). SDH patients were less likely to have pneumonia (0.492 [0.330-0.734]; p < 0.001), whereas alcohol abuse (4.21 [2.82-6.28]; p < 0.001) was more common. In SAH, ischaemic heart disease (0.56 [0.40-0.79]; p < 0.001) was less common. As expected, a range of cardiovascular risk factors were associated with ischaemic stroke. Epilepsy was positively associated with ischaemic stroke (1.94 [1.36-2.76], p < 0.001) indicating a role for targeted primary prevention in patients with epilepsy. Five-year survival was lower in ischaemic and haemorrhagic strokes (41% and 40% respectively, versus 73% in SDH and 64% in SAH; p < 0.001). These findings may guide clinical risk stratification, and improve the prognostic information given to patients.International Journal of Neuroscience 06/2014; DOI:10.3109/00207454.2014.930463 · 1.53 Impact Factor